Official websites use .gov
Secure .gov websites use HTTPS
« Previous
Next »
Titles
- BCG-unresponsive nonmuscle invasive bladder cancer: developing drugs and biologics for treatment1
- BPC’s key considerations for developing a Medicaid home and community-based services benefit1
- Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion1
- Bacterial vaginosis: developing drugs for treatment1
- Basic safety and essential performance of medical electrical equipment, medical electrical systems, and laboratory medical equipment: standards specific information for the Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program : guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff1
- Behavioral health and COVID-19: higher-risk populations and related federal relief funding : report to congressional committees1
- Behavioral health diagnoses and treatment services for children and youth involved with the child welfare system1
- Behavioral health in rural America: challenges and opportunities1
- Behavioral health: Available workforce information and federal actions to help recruit and retain providers : report to congressional requesters1
- Benefit-risk assessment for new drug and biological products: guidance for industry1
- Best practices for communication between IND sponsors and FDA during drug development: guidance for industry and review staff : good review practice1
- Best practices for convening a GRAS panel: guidance for industry1
- Best practices in developing proprietary names for human prescription drug products1
- Billions in estimated Medicare Advantage payments from chart reviews raise concerns1
- Billions in estimated Medicare Advantage payments from diagnoses reported only on health risk assessments raise concerns1
- Bioanalytical method validation1
- Bioavailability studies submitted in NDAs or INDs: general considerations1
- Biocompatibility testing of medical devices: standards specific information for the Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program : guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff1
- Biodefense: federal efforts to develop biological threat awareness : report to Congressional requesters1
- Biological product deviation reporting for blood and plasma establishments1